|Slideshows|July 12, 2018
Pros and Cons of Medication-Assisted Treatment for Opioid Use Disorder
Author(s)Arthur Robin Williams, MD, MBE
Although these medication-assisted treatments have been approved by the FDA and have strong empiric evidence for superior outcomes, it is important to know the good and the bad.
Advertisement
Newsletter
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves sNDA of Caplyta for the Prevention of Relapse in Schizophrenia
2
The Latest Data on Psychedelic DT120 ODT With Daniel R. Karlin, MD, MA
3
Accelerated FDA Action for Psychedelics: Insights From Daniel R. Karlin, MD, MA
4
FDA Fast-Tracks Psychedelic Therapies for Depression, PTSD, and Alcohol Use Disorder
5